NRBP1 is downregulated in breast cancer and NRBP1 overexpression inhibits cancer cell proliferation through Wnt/β-catenin signaling pathway
about
DNA hypomethylation of a transcription factor binding site within the promoter of a gout risk gene NRBP1 upregulates its expression by inhibition of TFAP2A bindingNRBP2 Overexpression Inhibits Cell Proliferation and Migration and Increases Cisplatin Sensitivity in Intrahepatic Cholangiocarcinoma.Nuclear receptor binding protein 1 correlates with better prognosis and induces caspase-dependent intrinsic apoptosis through the JNK signalling pathway in colorectal cancer.A new risk score based on twelve hepatocellular carcinoma-specific gene expression can predict the patients' prognosis
P2860
NRBP1 is downregulated in breast cancer and NRBP1 overexpression inhibits cancer cell proliferation through Wnt/β-catenin signaling pathway
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh
2015年學術文章
@zh-hant
name
NRBP1 is downregulated in brea ...... nt/β-catenin signaling pathway
@ast
NRBP1 is downregulated in brea ...... nt/β-catenin signaling pathway
@en
type
label
NRBP1 is downregulated in brea ...... nt/β-catenin signaling pathway
@ast
NRBP1 is downregulated in brea ...... nt/β-catenin signaling pathway
@en
prefLabel
NRBP1 is downregulated in brea ...... nt/β-catenin signaling pathway
@ast
NRBP1 is downregulated in brea ...... nt/β-catenin signaling pathway
@en
P2093
P2860
P356
P1476
NRBP1 is downregulated in brea ...... nt/β-catenin signaling pathway
@en
P2093
P2860
P304
P356
10.2147/OTT.S89779
P407
P577
2015-12-14T00:00:00Z